ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,807 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselVaderis Therapeutics AG
Vaderis Therapeutics AG Logo
Verified· 3 sources

Vaderis Therapeutics AG

Summary

About the company

The core activity of Vaderis Therapeutics AG is the development of medications, particularly in the areas of rare diseases, nephrology, vascular diseases, fibrosis, anti-infectives, and immunology. The company focuses on the early clinical development of new molecules and has experience in collaborating with companies such as Novartis.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Development of therapies for HHT
Development of targeted therapies for Hereditary Hemorrhagic Telangiectasia (HHT) and other rare vascular diseases, from scientific target definition to clinical development.
Clinical development of Engasertib
Clinical development of Engasertib as a selective AKT1/2 inhibitor for the treatment of HHT, focusing on the pipeline and clinical trials.
Research into rare vascular diseases
Research into HHT pathophysiology, vascular signalling pathways and genetic causes to develop targeted interventions against abnormal blood vessel formation.
Clinical trials
Conducting and using clinical trials as a preferred access route to investigational medicinal products for patients with HHT.
Press

Media

August 22, 2022Media
From stealth mode into clinical trials
startupticker.ch

Knowledge

No knowledge articles yet

Once Vaderis Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Vaderis Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Vaderis Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Vaderis Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Lichtstrasse 35
4056 Basel
Opening hours
Mon
08:00 - 20:00
Tue
08:00 - 20:00
Wed
08:00 - 20:00
Thu
08:00 - 20:00
Fri
08:00 - 20:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-464.916.458
Founded
2024 · 2 years
Last commercial register change
December 4, 2025
Employees
21 to 50

Similar companies

SA
SpiroChem AG
Basel
SA
Scailyte AG
Basel
ST
Synendos Therapeutics AG
Basel
TT
TargImmune Therapeutics AG
Basel